[HTML][HTML] Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease

O Corbali, T Chitnis - Frontiers in Neurology, 2023 - frontiersin.org
Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases,
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …

[HTML][HTML] Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide

JY Hor, K Fujihara - Frontiers in Neurology, 2023 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …

Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease

H Boudjani, G Fadda, G Dufort, J Antel… - Multiple Sclerosis and …, 2023 - Elsevier
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is
a recently described neuroinflammatory demyelinating disease. Objective To better …

Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody–associated disease

A Cobo‐Calvo, A Ruiz, F Rollot… - Annals of …, 2021 - Wiley Online Library
Objective The main objective was to compare clinical features, disease course, and myelin
oligodendrocyte glycoprotein (MOG) antibody (Ab) dynamics between children and adults …

[HTML][HTML] The expanding clinical spectrum of myelin oligodendrocyte glycoprotein (MOG) antibody associated disease in children and adults

E Parrotta, I Kister - Frontiers in Neurology, 2020 - frontiersin.org
The ability of MOG antibody (MOG-Ab) to induce autoimmune disease in animals has been
known for decades (1), but it is only recently since the cell-based assay for MOG-Ab IgG1 …

Myelin Oligodendrocyte Glycoprotein–Associated Disorders

E Longbrake - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW Anti–myelin oligodendrocyte glycoprotein (MOG) autoantibodies
have become a recognized cause of a pathophysiologically distinct group of central nervous …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management

W Ambrosius, S Michalak, W Kozubski… - International journal of …, 2020 - mdpi.com
Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare,
antibody-mediated inflammatory demyelinating disorder of the central nervous system …

Temporal dynamics of MOG antibodies in children with acquired demyelinating syndrome

EM Wendel, HS Thonke, A Bertolini… - Neurology …, 2022 - AAN Enterprises
Background and Objective The spectrum of myelin oligodendrocyte glycoprotein (MOG)
antibody–associated disorder (MOGAD) comprises monophasic diseases such as acute …

[HTML][HTML] Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: review of a novel clinico-radiographic spectrum

A Budhram, A Mirian, M Sharma - Frontiers in Neurology, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease that is distinct from multiple sclerosis. Initial …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …